Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial.
Zhou C, Chen G, Huang Y, Zhou J, Lin L, Feng J, Wang Z, Shu Y, Shi J, Hu Y, Wang Q, Cheng Y, Wu F, Chen J, Lin X, Wang Y, Huang J, Cui J, Cao L, Liu Y, Zhang Y, Pan Y, Zhao J, Wang L, Chang J, Chen Q, Ren X, Zhang W, Fan Y, He Z, Fang J, Gu K, Dong X, Zhang T, Shi W, Zou J; CameL Study Group. Zhou C, et al. Lancet Respir Med. 2020 Dec 18:S2213-2600(20)30365-9. doi: 10.1016/S2213-2600(20)30365-9. Online ahead of print. Lancet Respir Med. 2020. PMID: 33347829
Microvolt T-wave alternans complemented with electrophysiologic study for prediction of ventricular tachyarrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: a long-term follow-up study.
Xue SL, Hou XF, Sun KY, Wang Y, Qian ZY, Wang QP, Shen SP, Yin HL, Zhang R, Yin HP, Zou JG. Xue SL, et al. Among authors: zou jg. Chin Med J (Engl). 2019 Jun 20;132(12):1406-1413. doi: 10.1097/CM9.0000000000000239. Chin Med J (Engl). 2019. PMID: 31205097 Free PMC article.
49 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page